Tag: FDA

Dr. Marty Makary

Here’s the 411 on FDA Commissioner Nominee Martin Makary, MD, MPH

slide_Legislative1

Post-Election Healthcare Update: What the 2024 Elections Mean for the Policy Landscape Regulating Healthcare Marketers and Publishers

Sen. John Thune

2025 Congressional Leadership on Healthcare Issues

FDA-headquarters

Current FDA Voluntary Pre-Publication Rx Ad Review Processes

FDA-headquarters

FDA Issues Long-Awaited Final Rule for DTC Prescription Drug Ads

FTC Building for CHC Washington Insider Mast Head 5-23

FTC Proposes Changes to Health Breach Notification Rule to Strengthen Health App Applicability

FTC Building for CHC Washington Insider Mast Head 5-23

4A’s Submits Comments to FTC on Environmental Claims in Marketing (i.e. “Green Guides”)

CDER.News

FDA Accelerated Approval Program Is Under Spotlight Again with Makena

CHC_general1

FDA Proposes Increased Consumer Access to Nonprescription Drugs, with Conditions